Business Description
Medigus Ltd
NAICS : 423450
SIC : 5047
Share Class Description:
MDGSW: Warrants - Series C (23/07/2023)Total Employee Number:
38Description
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.14 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | -0.91 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3.93 | |||||
Beneish M-Score | -3.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.7 | |||||
3-Year EPS without NRI Growth Rate | 23.4 | |||||
3-Year FCF Growth Rate | 48.5 | |||||
3-Year Book Growth Rate | -35.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.14 | |||||
Quick Ratio | 1.14 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 38.82 | |||||
Days Sales Outstanding | 83.6 | |||||
Days Payable | 148.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.6 | |||||
Shareholder Yield % | 51.68 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.38 | |||||
Operating Margin % | -28.45 | |||||
Net Margin % | -20.19 | |||||
EBITDA Margin % | -25.14 | |||||
ROE % | -31.86 | |||||
ROA % | -12.85 | |||||
ROIC % | -24.52 | |||||
3-Year ROIIC % | 7.32 | |||||
ROC (Joel Greenblatt) % | -3320.14 | |||||
ROCE % | -46.34 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.13 | |||||
PB Ratio | 0.23 | |||||
EV-to-EBIT | 0.15 | |||||
EV-to-EBITDA | 0.23 | |||||
EV-to-Revenue | -0.06 | |||||
EV-to-FCF | 0.93 | |||||
Earnings Yield (Greenblatt) % | 666.67 | |||||
FCF Yield % | -28.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MDGSW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medigus Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 0.64 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medigus Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medigus Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2025 | 2026-04-30 | -- | ||
| First quarter earnings results for 2026 | 2026-04-15 | -- | ||
| Third quarter earnings results for 2025 | 2025-11-14 | -- | ||
| General meeting for 2024 | 2025-08-26 | -- | ||
| Second quarter earnings results for 2025 | 2025-08-22 | -- | ||
| Annual report for 2024 | 2025-04-30 | -- |
Show
Entries
Medigus Ltd Frequently Asked Questions
What is Medigus Ltd(MDGSW)'s stock price today?
The current price of MDGSW is $0.02. The 52 week high of MDGSW is $0.64 and 52 week low is $0.00.
When is next earnings date of Medigus Ltd(MDGSW)?
The next earnings date of Medigus Ltd(MDGSW) is 2026-11-14 Est..
Does Medigus Ltd(MDGSW) pay dividends? If so, how much?
Medigus Ltd(MDGSW) does not pay dividend.
Press Release
Articles on Medigus Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers